| NK cells and T cells cooperate during the clinical course of colorectal cancer G Sconocchia, S Eppenberger, GC Spagnoli, L Tornillo, R Droeser, ... Oncoimmunology 3 (8), e952197, 2014 | 166 | 2014 |
| HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic marker G Sconocchia, S Eppenberger-Castori, I Zlobec, E Karamitopoulou, ... Neoplasia 16 (1), 31-W15, 2014 | 116 | 2014 |
| Peroxiredoxin 6, a novel player in the pathogenesis of diabetes F Pacifici, R Arriga, GP Sorice, B Capuani, MG Scioli, D Pastore, ... Diabetes 63 (10), 3210-3220, 2014 | 101 | 2014 |
| FCγ chimeric receptor-engineered T cells: methodology, advantages, limitations, and clinical relevance S Caratelli, T Sconocchia, R Arriga, A Coppola, G Lanzilli, D Lauro, ... Frontiers in Immunology 8, 457, 2017 | 59 | 2017 |
| T lymphocytes engineered to express a CD16-chimeric antigen receptor redirect T-cell immune responses against immunoglobulin G–opsonized target cells MM D'Aloia, S Caratelli, C Palumbo, S Battella, R Arriga, D Lauro, ... Cytotherapy 18 (2), 278-290, 2016 | 51 | 2016 |
| In vitro elimination of epidermal growth factor receptor‐overexpressing cancer cells by CD32A‐chimeric receptor T cells in combination with cetuximab or … S Caratelli, R Arriga, T Sconocchia, A Ottaviani, G Lanzilli, D Pastore, ... International journal of cancer 146 (1), 236-247, 2020 | 35 | 2020 |
| Serum glucocorticoid inducible kinase (SGK)-1 protects endothelial cells against oxidative stress and apoptosis induced by hyperglycaemia F Ferrelli, D Pastore, B Capuani, MF Lombardo, M Blot-Chabaud, ... Acta diabetologica 52, 55-64, 2015 | 34 | 2015 |
| Recent perspective on CAR and Fcγ-CR T cell immunotherapy for cancers: preclinical evidence versus clinical outcomes HE Marei, A Althani, T Caceci, R Arriga, T Sconocchia, A Ottaviani, ... Biochemical Pharmacology 166, 335-346, 2019 | 27 | 2019 |
| HLA‐DRB1* 13: 01 allele in the genetic susceptibility to colorectal carcinoma A Aureli, A Canossi, T Del Beato, L Franceschilli, O Buonomo, F Papola, ... International journal of cancer 136 (10), 2464-2468, 2015 | 22 | 2015 |
| CD16‐158‐valine chimeric receptor T cells overcome the resistance of KRAS‐mutated colorectal carcinoma cells to cetuximab R Arriga, S Caratelli, G Lanzilli, A Ottaviani, C Cenciarelli, T Sconocchia, ... International journal of cancer 146 (9), 2531-2538, 2020 | 20 | 2020 |
| Enhancement of anti-leukemia activity of NK cells in vitro and in vivo by inhibition of leukemia cell-induced NK cell damage R Arriga, S Caratelli, A Coppola, GC Spagnoli, A Venditti, S Amadori, ... Oncotarget 7 (2), 2070, 2016 | 16 | 2016 |
| Glioma extracellular vesicles for precision medicine: Prognostic and theragnostic application HE Marei, A Althani, N Afifi, A Hasan, T Caceci, I Cifola, S Caratelli, ... Discover Oncology 13 (1), 49, 2022 | 14 | 2022 |
| Contribution of A-to-I RNA editing, M6A RNA Methylation, and Alternative Splicing to physiological brain aging and neurodegenerative diseases V Tassinari, P La Rosa, E Guida, A Colopi, S Caratelli, F De Paolis, ... Mechanisms of ageing and development 212, 111807, 2023 | 11 | 2023 |
| Liver protein profiles in insulin receptor-knockout mice reveal novel molecules involved in the diabetes pathophysiology B Capuani, D Della-Morte, G Donadel, S Caratelli, L Bova, D Pastore, ... American Journal of Physiology-Endocrinology and Metabolism 308 (9), E744-E755, 2015 | 10 | 2015 |
| Metformin inhibits leptin release induced by HMGB1 and exerts an anti-inflammatory action reducing TLR4/2 expression in T2D subjects A Coppola, MP Caputo, D Pastore, B Capuani, V Ferrazzoli, F Pacifici, ... Diabetes 64, A473-A473, 2015 | 4 | 2015 |
| Leukaemia and epithelial cancer cells trigger NK cell storming: the NK cell alloperturbation phenomenon G Sconocchia, R Arriga, S Caratelli, K Basello, A Coppola, B Capuani, ... BONE MARROW TRANSPLANTATION 46, S325-S325, 2011 | 2 | 2011 |
| Direct CD32 T-cell cytotoxicity: implications for breast cancer prognosis and treatment G Sconocchia, G Lanzilli, V Cesarini, DA Silvestris, K Rezvani, R Arriga, ... Life science alliance 5 (12), 2022 | 1 | 2022 |
| EGFR+ Glioblastoma Stem Cells Targeting by CD16158V-Chimeric Receptor T Cells and Cetuximab C Cenciarelli, S Caratelli, R Arriga, G Lanzilli, A Ottaviani, T Sconocchia, ... J. Res 1, 24-35, 2021 | 1 | 2021 |
| In vitro elimination of EGFR-overexpressing cancer cells by CD32A chimeric receptor T cells in combination with cetuximab or panitumumab S Caratelli, R Arriga, T Sconocchia, A Ottaviani, G Lanzilli, D Pastore, ... INTERNATIONAL JOURNAL OF CANCER 146 (1), 236-247, 2020 | 1 | 2020 |
| IL-2 activated natural killer cells release leptin after high mobility group box-1 stimulation A Coppola, M Caputo, B Capuani, D Pastore, F Pacifici, R Arriga, ... Diabetes 63, A75-A75, 2014 | 1 | 2014 |
